2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Highlights on Metastatic Melanoma: What Is the Optimal Dosing of Ipilimumab + Nivolumab?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Gary Doolittle
By 2020 ASCO Virtual Direct™ Highlights FEATURING Gary Doolittle
182 views
July 22, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
Skin
10:19

2020 ASCO Update on TILs in Advanced Melanoma: Does Lifileucel Impro…

2020 ASCO Virtual Direct™ Highlights

G. Doolittle

81 views
08:45

2020 ASCO Highlights on Metastatic Melanoma: What Is the Optimal Dos…

2020 ASCO Virtual Direct™ Highlights

G. Doolittle

182 views
13:37

2020 ASCO Update on High-risk Resectable Stage III Melanoma: Can 2 C…

2020 ASCO Virtual Direct™ Highlights

G. Doolittle

202 views
05:54

2020 ASCO Follow up on Adjuvant Therapy in High-risk Melanoma: Does …

2020 ASCO Virtual Direct™ Highlights

G. Doolittle

104 views